Bansisons Tea Industries Ltd — Board Meeting, 26-01-2026: Board Meeting
26-01-2026 | 07:05 pm
26-01-2026 | 07:05 pm
Novyra Pharmachem's Board approved financial results for the third quarter and nine months ended Dec 31, 2025. The company reported a net loss of ₹1.15 Lakhs for the quarter and ₹1.82 Lakhs for the nine-month period.
No comments yet. Be the first to comment!
